GlassScriptPhysician profile
Priyanka Jain
NPI 1275791881
$1,496.88
in general payments reported to CMS, 2019-2025
17 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.26 · 2020: $90.82 · 2021: $281 · 2022: $540 · 2023: $285 · 2024: $60.80 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $256 · Long Term Medical Supply Or Device Loan: $241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $256.22 |
| Long Term Medical Supply Or Device Loan | $240.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $606.71 | 2022-2023 | Cirrus Hd-Oct |
| Allergan, INC. | $201.13 | 2019-2021 | |
| Glaukos Corporation | $139.55 | 2021-2022 | |
| Amgen INC. | $120.85 | 2024-2025 | Tepezza |
| Alcon Vision LLC | $67.17 | 2020-2025 | Rocklatan, Tryptyr |
| Tarsus Pharmaceuticals, INC. | $49.55 | 2024-2025 | Xdemvy |
| Genentech USA, INC. | $46.80 | 2022 | |
| Bausch & Lomb Americas INC. | $44.06 | 2023 | Vyzulta |
| Irhythm Technologies, INC. | $38.68 | 2019 | |
| Novartis Pharmaceuticals Corporation | $38.34 | 2021 | |
| Aerie Pharmaceuticals, INC. | $34.93 | 2020-2021 | |
| Biotissue Holdings INC. | $29.74 | 2021 | |
| Mallinckrodt Hospital Products INC. | $20.66 | 2021 | |
| Alimera Sciences, INC. | $20.24 | 2020 | |
| Vanda Pharmaceuticals INC. | $13.25 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.10 | 2019 | |
| Abbvie INC. | $12.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priyanka Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.